Mary Jane England Sells 3,600 Shares of Healthways Inc. (HWAY) Stock
Healthways Inc. (NASDAQ:HWAY) Director Mary Jane England sold 3,600 shares of the business’s stock in a transaction on Friday, November 18th. The stock was sold at an average price of $22.26, for a total transaction of $80,136.00. Following the completion of the sale, the director now directly owns 30,871 shares of the company’s stock, valued at $687,188.46. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Mary Jane England also recently made the following trade(s):
- On Friday, August 26th, Mary Jane England sold 3,816 shares of Healthways stock. The stock was sold at an average price of $24.78, for a total transaction of $94,560.48.
Healthways Inc. (NASDAQ:HWAY) opened at 22.70 on Tuesday. The company’s market capitalization is $878.10 million. The stock’s 50 day moving average is $23.93 and its 200 day moving average is $18.88. Healthways Inc. has a 52 week low of $9.18 and a 52 week high of $27.30.
Healthways (NASDAQ:HWAY) last issued its quarterly earnings data on Tuesday, November 1st. The company reported $0.30 EPS for the quarter, missing analysts’ consensus estimates of $0.52 by $0.22. Healthways had a positive return on equity of 13.49% and a negative net margin of 24.50%. The business earned $125 million during the quarter, compared to analysts’ expectations of $124.71 million. During the same period in the previous year, the business earned $0.35 earnings per share. The business’s quarterly revenue was up 10.1% on a year-over-year basis. On average, equities research analysts expect that Healthways Inc. will post $1.64 earnings per share for the current year.
Several institutional investors have recently modified their holdings of the company. Jane Street Group LLC acquired a new position in shares of Healthways during the third quarter worth approximately $841,000. Fuller & Thaler Asset Management Inc. acquired a new position in shares of Healthways during the third quarter worth approximately $9,239,000. D. E. Shaw & Co. Inc. boosted its position in shares of Healthways by 14.5% in the third quarter. D. E. Shaw & Co. Inc. now owns 791,939 shares of the company’s stock worth $20,955,000 after buying an additional 100,180 shares during the last quarter. The Manufacturers Life Insurance Company acquired a new position in shares of Healthways during the third quarter worth approximately $592,000. Finally, Analytic Investors LLC acquired a new position in shares of Healthways during the third quarter worth approximately $1,849,000. 94.03% of the stock is owned by institutional investors and hedge funds.
Several analysts have weighed in on HWAY shares. Zacks Investment Research raised shares of Healthways from a “hold” rating to a “buy” rating and set a $23.00 price target for the company in a research note on Thursday, November 3rd. Barclays PLC raised shares of Healthways from an “underweight” rating to an “equal weight” rating and boosted their price target for the stock from $12.00 to $27.00 in a research note on Monday, August 22nd. Jefferies Group boosted their price target on shares of Healthways from $13.00 to $18.50 and gave the stock a “hold” rating in a research note on Thursday, August 4th. Barrington Research reissued an “outperform” rating and issued a $30.00 price target (up from $29.00) on shares of Healthways in a research note on Thursday, October 13th. Finally, FBR & Co boosted their price target on shares of Healthways from $16.00 to $21.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 10th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and four have issued a buy rating to the company’s stock. Healthways currently has a consensus rating of “Hold” and an average target price of $25.64.
Healthways Company Profile
Healthways, Inc (Healthways) provides network delivered solutions and population health management services that are designed to help people manage their wellbeing, thereby managing their health and productivity, and their health-related costs. The Company operates in the domestic and international segments, which are collectively known as the well-being improvement services segment.
Receive News & Stock Ratings for Healthways Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthways Inc. and related stocks with our FREE daily email newsletter.